{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:22:16Z","timestamp":1780950136319,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00520-025-09975-9","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:16:47Z","timestamp":1759522607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in nutritional status in hepatocellular carcinoma patients treated with sorafenib"],"prefix":"10.1007","volume":"33","author":[{"given":"Rados\u0142aw","family":"Osma\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Mardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Radomyski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Litwiniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Stelmach-Mardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"3","key":"9975_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"9975_CR2","unstructured":"Didkowska JA, Wojciechowska U, Bara\u0144ska K, Miklewska M, Micha\u0142ek I, Olasek P (2023) Nowotwory z\u0142o\u015bliwe w Polsce w 2021 roku. Warszawa https:\/\/onkologia.org.pl\/sites\/default\/files\/publications\/2024-02\/0_krn-2023-book-2024-02-13-pass.pdf"},{"key":"9975_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S et al (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6","journal-title":"Nat Rev Dis Primers"},{"key":"9975_CR4","volume":"3","author":"V Nagalapuram","year":"2025","unstructured":"Nagalapuram V, Popuri N, Nipp RD, Ulahannan SV, Lau-Min KS (2025) Management of advanced hepatocellular carcinoma: a review and practical guide. JCO Oncol Pract 3:OP2400872","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"9975_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/lt.25742","volume":"26","author":"MA Dunn","year":"2020","unstructured":"Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC (2020) Physical function, physical activity, and quality of life after liver transplantation. Liver Transpl 26(5):702\u2013708","journal-title":"Liver Transpl"},{"issue":"3","key":"9975_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cancers17030409","volume":"17","author":"H Li","year":"2025","unstructured":"Li H, Vogl TJ, Chen KA, Adwan H (2025) A comparison of the efficacy and safety of US-, CT-, and MR-guided radiofrequency and microwave ablation for HCC: a systematic review and network meta-analysis. Cancers (Basel) 17(3):409","journal-title":"Cancers (Basel)"},{"key":"9975_CR7","unstructured":"Krzakowski M, Warzocha K, Stelmach A, Potemski P (2013) Zalecenia Post\u0119powania Diagnostyczno-Terapeutycznego w Nowotworach Z\u0142o\u015bliwych. Volume 3. Via Medica; Gda\u0144sk, Poland: pp. 25\u201335"},{"issue":"Suppl 4","key":"9975_CR8","doi-asserted-by":"publisher","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","volume":"29","author":"A Vogel","year":"2018","unstructured":"Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T et al (2018) ESMO Guidelines Committee. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv238\u2013iv255","journal-title":"Ann Oncol"},{"issue":"9","key":"9975_CR9","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11136-024-03715-y","volume":"33","author":"R Fillipo","year":"2024","unstructured":"Fillipo R, Leblanc TW, Plyler KE, Arizmendi C, Henke DM, Coles T (2024) How do patients interpret and respond to a novel patient-reported eastern cooperative oncology group performance status (ECOG)? Qual Life Res 33(9):2375\u20132385","journal-title":"Qual Life Res"},{"key":"9975_CR10","unstructured":"Tsoris A, Marlar CA. Use of the Child Pugh score in liver disease. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542308\/"},{"issue":"1","key":"9975_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jhep.2003.09.027","volume":"40","author":"U Cillo","year":"2004","unstructured":"Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S et al (2004) The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 40(1):124\u2013131","journal-title":"J Hepatol"},{"issue":"10","key":"9975_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/hepr.12774","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S (2016) Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 46(10):951\u2013963","journal-title":"Hepatol Res"},{"issue":"3","key":"9975_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","volume":"34","author":"T Cederholm","year":"2015","unstructured":"Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S et al (2015) Diagnostic criteria for malnutrition - an ESPEN consensus statement. Clin Nutr 34(3):335\u2013340","journal-title":"Clin Nutr"},{"issue":"3","key":"9975_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/jamaoncol.2023.2677","volume":"10","author":"S Cappuyns","year":"2024","unstructured":"Cappuyns S, Corbett V, Yarchoan M, Finn RS, Llovet JM (2024) Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma: a review. JAMA Oncol 10(3):395\u2013404","journal-title":"JAMA Oncol"},{"issue":"2","key":"9975_CR15","first-page":"116","volume":"33","author":"P Chonmaitree","year":"2025","unstructured":"Chonmaitree P, Sudcharoen A, Poonyam P, Laoarphasuwong N, Khuancharee K, Thititagul O (2025) Comparison of Patient-Generated Subjective Global Assessment (PG-SGA) and Mini Nutritional Assessment (MNA) for nutritional assessment in hepatocellular carcinoma patients. Support Care Cancer 33(2):116","journal-title":"Support Care Cancer"},{"issue":"4","key":"9975_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/01635581.2024.2314317","volume":"76","author":"S Tan","year":"2024","unstructured":"Tan S, Jiang J, Qiu L, Liang Y, Meng J, Tan N et al (2024) Prevalence of malnutrition in patients with hepatocellular carcinoma: a comparative study of GLIM criteria, NRS2002, and PG-SGA, and identification of independent risk factors. Nutr Cancer 76(4):335\u2013344","journal-title":"Nutr Cancer"},{"issue":"1","key":"9975_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12876-024-03438-x","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Jiang M, Hua X, Xu H, Wu M, Wu J et al (2024) Reduced muscle mass is an important part of Global Leadership Initiative on Malnutrition criteria in nutritional diagnosis of hepatocellular carcinoma. BMC Gastroenterol 24(1):358","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"9975_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2024.08.001","volume":"29","author":"R Gujarathi","year":"2025","unstructured":"Gujarathi R, Klein JA, Liao CY, Pillai A (2025) The changing demographics and epidemiology of hepatocellular carcinoma. Clin Liver Dis 29(1):1\u201315","journal-title":"Clin Liver Dis"},{"issue":"11","key":"9975_CR19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s11912-024-01605-7","volume":"26","author":"JG Chen","year":"2024","unstructured":"Chen JG, Zhang YH, Lu JH, Kensler TW (2024) Liver cancer etiology: old issues and new perspectives. Curr Oncol Rep 26(11):1452\u20131468","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"9975_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/COC.0000000000000388","volume":"41","author":"A Gupta","year":"2018","unstructured":"Gupta A, Das A, Majumder K, Arora N, Mayo HG, Singh PP et al (2018) Obesity is independently associated with increased risk of hepatocellular cancer-related mortality: a systematic review and meta-analysis. Am J Clin Oncol 41(9):874\u2013881","journal-title":"Am J Clin Oncol"},{"issue":"13","key":"9975_CR21","doi-asserted-by":"publisher","first-page":"1061091","DOI":"10.3389\/fendo.2022.1061091","volume":"12","author":"NN Feng","year":"2023","unstructured":"Feng NN, Du XY, Zhang YS, Jiao ZK, Wu XH, Yang BM (2023) Overweight\/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. Front Endocrinol (Lausanne) 12(13):1061091","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"31","key":"9975_CR22","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.1097\/MD.0000000000001269","volume":"94","author":"X Rong","year":"2015","unstructured":"Rong X, Wei F, Geng Q, Ruan J, Shen H, Li A et al (2015) The association between body mass index and the prognosis and postoperative complications of hepatocellular carcinoma: a meta-analysis. Med (Baltimore) 94(31):e1269","journal-title":"Med (Baltimore)"},{"issue":"2","key":"9975_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11547-024-01933-5","volume":"130","author":"J Ouyang","year":"2025","unstructured":"Ouyang J, Yang Y, Xu Y, Wang Z, Zhou Y, Zhao H et al (2025) How different body compositions affect the prognosis of HCC undergoing immunotherapy: the paradoxical phenomenon of BMI. Radiol Med 130(2):258\u2013270","journal-title":"Radiol Med"},{"issue":"27","key":"9975_CR24","doi-asserted-by":"publisher","first-page":"e34292","DOI":"10.1097\/MD.0000000000034292","volume":"102","author":"Y Li","year":"2023","unstructured":"Li Y, Hou J, Chen R (2023) Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE. Med (Baltimore) 102(27):e34292","journal-title":"Med (Baltimore)"},{"key":"9975_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1433528","volume":"11","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li D, Li J (2024) Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a meta-analysis and systemic review. Front Nutr 11:1433528","journal-title":"Front Nutr"},{"issue":"8","key":"9975_CR26","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/bjc.2012.92","volume":"106","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, North BV, Sharma R (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106(8):1439\u20131445","journal-title":"Br J Cancer"},{"issue":"4","key":"9975_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5582\/bst.2024.01235","volume":"18","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen L, Song P, Zhu C, Tang L (2024) Potential value and advances in research on bone mineral density (BMD) measurement in the auxiliary clinical assessment of hepatocellular carcinoma. Biosci Trends 18(4):398\u2013403","journal-title":"Biosci Trends"},{"key":"9975_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2258567","author":"N Luo","year":"2023","unstructured":"Luo N, Li H, Luo Y, Hu P, Liang L, Zhang R et al (2023) Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2023.2258567","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"9975_CR29","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/MEG.0000000000002346","volume":"34","author":"K Ogushi","year":"2022","unstructured":"Ogushi K, Chuma M, Numata K, Nozaki A, Moriya S, Uojima H et al (2022) Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients. Eur J Gastroenterol Hepatol 34(7):774\u2013781","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"9975_CR30","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s00261-024-04439-w","volume":"49","author":"C Rao","year":"2024","unstructured":"Rao C, Chen J, Xu K, Xue C, Wu L, Huang X et al (2024) Association of magnetic resonance imaging-derived sarcopenia with outcomes of patients with hepatocellular carcinoma after hepatectomy. Abdom Radiol 49(7):2272\u20132284","journal-title":"Abdom Radiol"},{"issue":"6","key":"9975_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1159\/000529676","volume":"12","author":"CH Wu","year":"2023","unstructured":"Wu CH, Ho MC, Chen CH, Liang JD, Huang KW, Cheng MF et al (2023) Computed tomography-defined sarcopenia in outcomes of patients with unresectable hepatocellular carcinoma undergoing radioembolization: assessment with total abdominal, psoas, and paraspinal muscles. Liver Cancer 12(6):550\u2013564","journal-title":"Liver Cancer"},{"key":"9975_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijsu.2016.04.049","volume":"30","author":"N Yabusaki","year":"2016","unstructured":"Yabusaki N, Fujii T, Yamada S, Suzuki K, Sugimoto H, Kanda M et al (2016) Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection. Int J Surg 30:136\u2013142","journal-title":"Int J Surg"},{"issue":"1","key":"9975_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2395062","volume":"56","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li X, Wang K, Wu M, Liu W, Wang W (2024) Prognostic impact of body composition in hepatocellular carcinoma patients with immunotherapy. Ann Med 56(1):2395062","journal-title":"Ann Med"},{"issue":"5","key":"9975_CR34","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/jcsm.13554","volume":"15","author":"D Lu","year":"2024","unstructured":"Lu D, Hu Z, Chen H, Khan AA, Xu Q, Lin Z et al (2024) Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. J Cachexia Sarcopenia Muscle 15(5):2071\u20132083","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"9975_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16237","volume":"45","author":"PC Lee","year":"2025","unstructured":"Lee PC, Cheng TY, Ho CT, Huang KW, Chau GY, Huang YH et al (2025) Gender different impacts of muscle mass and adipose tissue on patients with hepatocellular carcinoma undergoing surgical resection. Liver Int 45(2):e16237","journal-title":"Liver Int"},{"issue":"2","key":"9975_CR36","doi-asserted-by":"publisher","first-page":"854","DOI":"10.21037\/tcr-20-2974","volume":"10","author":"HY Jang","year":"2021","unstructured":"Jang HY, Choi GH, Hwang SH, Jang ES, Kim JW, Ahn JM et al (2021) Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection. Transl Cancer Res 10(2):854\u2013866","journal-title":"Transl Cancer Res"},{"key":"9975_CR37","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2147\/JHC.S453262","volume":"11","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q et al (2024) The influence of visceral adiposity on overall survival: exploring \u201cobesity paradox\u201d among hepatocellular carcinoma patients who receiving immunotherapy. J Hepatocell Carcinoma 11:1193\u20131206","journal-title":"J Hepatocell Carcinoma"},{"issue":"17","key":"9975_CR38","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.3390\/cancers15174223","volume":"15","author":"K Imai","year":"2023","unstructured":"Imai K, Takai K, Unome S, Miwa T, Hanai T, Suetsugu A et al (2023) Lenvatinib or sorafenib treatment causing a decrease in skeletal muscle mass, an independent prognostic factor in hepatocellular carcinoma: a survival analysis using time-varying covariates. Cancers (Basel) 15(17):4223","journal-title":"Cancers (Basel)"},{"issue":"7","key":"9975_CR39","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/cancers12071795","volume":"12","author":"K Imai","year":"2020","unstructured":"Imai K, Takai K, Miwa T, Taguchi D, Hanai T, Suetsugu A et al (2020) Rapid depletion of subcutaneous adipose tissue during sorafenib treatment predicts poor survival in patients with hepatocellular carcinoma. Cancers (Basel) 12(7):1795","journal-title":"Cancers (Basel)"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09975-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T21:01:51Z","timestamp":1765659711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09975-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9975"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09975-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the local Bioethics Committee (No: 1134\/2024) at the Poznan University of Medical Science in Poland. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"901"}}